Perioperative and Postoperative Evaluation of Rectal and Urogenital Function in Patients Undergoing Rectal Resection
PERIFUNC
1 other identifier
observational
500
1 country
1
Brief Summary
The aim of this study is the systematic analysis of the development of perioperative rectal and urogenital function in patients undergoing rectal resection with total mesorectal excision and the identification of risk factors for urogenital and sphincter function loss after this procedure. Knowledge of the corresponding risk factors could enable the identification of patient cohorts that could benefit from an intensified or altered postoperative treatment path. The results of this study could thus significantly influence the clinical management of patients with rectal cancer and improve the functional outcome in the long term.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 3, 2021
CompletedFirst Submitted
Initial submission to the registry
February 7, 2022
CompletedFirst Posted
Study publicly available on registry
February 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2030
June 13, 2024
June 1, 2024
9.3 years
February 7, 2022
June 12, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Assessment of pelvic function before and after rectal resection
Rectal and urogenital function will be assessed preoperatively and 12-24 months and 5 years postoperatively using the PERIFUNC score questionnaire, resulting in a score between 0 and 120. Higher scores mean a worse outcome (worse pelvic function).
5 years
Rectal sphincter function before and after rectal resection
Sphincter function will be assessed by manometry preoperatively and 12 - 24 months and 5 years postoperatively
5 years
Assessment of stool continence before and after rectal resection
Stool continence will be assessed preoperatively and 12-24 months and 5 years postoperatively using the LARS score questionnaire, resulting in a score between 0 and 42. Higher scores mean a worse outcome (worse stool continence).
5 years
Secondary Outcomes (6)
Operating time [min]
during surgery
Intraoperative blood loss [mL]
during surgery
Duration of postoperative hospital stay [days]
At day of discharge, assessed up to 90 days
Duration of postoperative intermediate/intensive care unit stay [days]
At day of discharge, assessed up to 90 days
Frequency of peri-operative morbidity after resection
90 days after surgery
- +1 more secondary outcomes
Interventions
Open or minimally invasive rectal resection with total mesorectal excision
Eligibility Criteria
All patients undergoing rectal resection with total mesorectal excision
You may qualify if:
- Patients undergoing rectal resection with total mesorectal excision
You may not qualify if:
- primary or secondary removal of rectal sphincter apparatus
- patients with enterostomy persisting 12 months after initial rectal resection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Gastrointestinal-, Thoracic and Vascular Surgery University Hospital Carl Gustav Carus Technische Universität Dresden
Dresden, Saxony, 01307, Germany
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Johannes Fritzmann, Dr.
Technical University Dresden
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 7, 2022
First Posted
February 25, 2022
Study Start
March 3, 2021
Primary Completion (Estimated)
June 30, 2030
Study Completion (Estimated)
June 30, 2030
Last Updated
June 13, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share
Following publication of study results, de-identified patient data will be made available upon reasonable request